Interestingly, Immutep (Prima Biomed at the time) presented at last years Ladenburg Thalmann healthcare conference but there was no mention of it in company newsletters or announcements.
However, at the time of this conference, 26th September 2017, IMM shares were at trading at a low of 0.021 but during the week after the conference rose to a high of 0.035 on the back of large volume.
Ladenburg have access to 1000 financial instutions and 4000 independent financial advisors.
This year by comparison Immutep is a far stronger value proposition for potential investors......
Final results of TACTI-mel phase 1 trial to be presented by Frederic end of October at World Immunotherapy Congress , if good, 'light blue touch paper' comes to mind......imo of course.
Been in PRR/IMM for what seems like a lifetime (several actually).....
Interestingly, Immutep (Prima Biomed at the time) presented at...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.5¢ | $469.8K | 1.579M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 297652 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 7500 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |